SalvaRx Group invests $1m in US biotechnology firm

Maryam Cockar Sharecast | 20 Mar, 2017 10:09 - Updated: 10:09 | | |

pharmaceuticals, drugs, lab
  • 31.25
  • 3.31%1.00
  • Max: 31.25
  • Min: 30.25
  • Volume: 0
  • MM 200 : n/a
17:17 27/04/17
  • 7,483.95
  • 0.16%11.80
  • Max: 7,526.04
  • Min: 7,471.89
  • Volume: 0
  • MM 200 : n/a
09:10 28/04/17
  • 961.67
  • -0.02%-0.17
  • Max: 962.15
  • Min: 961.44
  • Volume: 0
  • MM 200 : n/a
09:10 28/04/17

SalvaRx Group is to invest $1m in Rift Biotherapeutics, a US biotechnology company that develops antibodies for use in oncology.

Following the investment, the company will hold about 30% stake in Rift, including new shares issued on the $90,000 loan already provided to Rift.

SalvaRx will have the option to invest up to $1.5m further if Rift achieves certain development targets, and will also have the option to buy all outstanding shares in Rift in exchange for new shares in SalvaRx.

Rift develops antibodies implicated in the inflammatory tumour and tumours infiltrating the immune cells microenvironment, and it recently won the Boehringer Ingelheim Innovation prize, which included additional laboratory space at BioLabs San Diego, an incubator for biotech start-ups.

SalvaRx chief executive Ian Walters said that the company’s collaboration with Rift will provide it with financing to finish preclinical development and will also augment its team with SalvaRx's clinical development expertise.

Dr Miguel de los Rios, Rift's founder and chief executive, added: "Our novel non T-cell based immunotherapy targets offer complementary approaches to the current standard of care in immuno-oncology. We are researching the anti-tumour activity of our immunotherapy and potential utility with standard of care agents such as Opdivo, Keytruda, or Tecentriq. “

More news

09:19 UK consumer confidence worsens again in April - GfK

UK consumer confidence worsened slightly in April due to worries about rising inflation and flat wages.

08:58 Ultra Electronics remains confident despite US funding delays

Ultra Electronics said the expected improvement in trading from the new US government continued to be delayed as Federal budgets were negotiated.

08:41 RBS swings into first quarterly profit since 2015

Royal Bank of Scotland broke into the black in the first quarter of 2017, the first quarterly profit since 2015 as income, costs and margins all improved.

09:01 UK house prices fall again in April, says Nationwide

UK house prices have fallen for the second month in a row, with annual growth slowing to a near four-year low.

00:11 US close: Wall Street closes in the green as earnings season peaks

Wall Street bounced back quickly but modestly on Thursday as the peak day of the earnings season was rather mixed, with investors still getting over their disappointment over White House tax cut plans the previous day.

27 Apr Lloyds Banking Group profit increases, on track to meet 2017 targets

Lloyds Banking Group’s first quarter profit increased with the part state-owned bank still on track to meet its 2017 targets.

27 Apr ECB policy decision - Analysts react

"In June we expect a change to a less dovish and more symmetric forward guidance that would open the door for depo rate hikes in 2018. In particular, we would expect modifications possibly to both the forward guidance on rates and on QE by removing the explicit reference in the statement to a scenario with lower rates and/or higher QE." - Philippe Gudin, Antonio Garcia Pascual, Barclays Research

27 Apr FX round-up: Sterling sails higher on UK retail data, ECB rate call

Sterling sailed higher on most key crosses Thursday as investors liked the currency after pleasing UK retail data, European Central Bank holding interest rates and last night's US tax-reform disappointment.

27 Apr Europe close: ECB pours cold water on expectations of policy shift

European stocks declined for the first time in seven days despite the European Central Bank sounding a more confident note on the single currency bloc's economy.

27 Apr Friday preview: UK economic growth seen slowing, RBS results under scrutiny

On Friday the Office for National Statistics will reveal its preliminary estimate for UK gross domestic product growth for the first quarter.